Reducing Intersectional and HIV Stigma among High Risk Women who use Drugs in Kazakhstan, Central Asia: A Multilevel Stigma Resistance and Enacted Stigma Reduction Intervention for Women and Providers
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Stigma HIV/AIDS
Project Information in NIH RePORTER
Reducing Intersectional and HIV Stigma among High Risk Women who use Drugs in Kazakhstan, Central Asia: A Multilevel Stigma Resistance and Enacted Stigma Reduction Intervention for Women and Providers
Principal Institution
Columbia University New York Morningside
Principal Investigator(s) (PI)
West, Brooke S.; Frye, Victoria
Project Contact Information
Email:
bsw2110@columbia.edu
Year(s) Awarded
2022–2025
Country
Kazakhstan
NIH Partners
NIDA
Project Description
Suboptimal linkage to and retention in HIV prevention and care is prevalent among high risk women who use or inject drugs in both the U.S. and globally, including high HIV incidence contexts like Kazakhstan. addressing HIV and intersectional stigma, especially from health care providers (HCP) within clinics, is necessary to increase engagement in the HIV care and prevention continuum.
To address this challenge and increase HIV prevention and care, the study will involve the design and assessment of the acceptability, feasibility, and usability of a three-component, multi-level participatory intervention to promote stigma resistance/coping and reduce anticipated/internalized stigma among high risk women who use drugs as well as to reduce enacted stigma among HCP in Kazakhstan.
Related Global Health Research Topics